Cafepharma Today

March 3 2025 - AbbVie pays Gubra $350M to make late play for obesity space
AbbVie pays Gubra $350M to make late play for obesity space
FDA recall notice details J&J pause of Varipulse
RFK Jr. move to kill public comment roils providers
GSK bows to Trump pressure and pauses diversity policies
*please scroll down for all the latest news*

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

More Changes Brewing At Pfizer
Forbes
Tuesday, October 7, 2008 - 4:42pm
tags:
Pfizer Reorganizes Into Three Business Units
Pharmalot
Tuesday, October 7, 2008 - 10:19am
tags:
Four Value Priced Stocks: Sysco, Eli Lilly, PepsiCo and Johnson & Johnson
Seeking Alpha
Tuesday, October 7, 2008 - 10:06am
tags:
Cypress Bioscience, Worth Watching for Fibromyalgia Drug
Cafepharma Detailpiece
Tuesday, October 7, 2008 - 10:05am
tags:
NCCN, Abraxis BioScience and AstraZeneca Announce Collaboration to Conduct Anti-Cancer Drug Studies
Yahoo
Tuesday, October 7, 2008 - 9:04am
tags:
Biotech ETFs Hold Their Own During Crisis
Seeking Alpha
Tuesday, October 7, 2008 - 8:47am
tags:
Drugmakers Urged By UK To Lower Prices
Pharmalot
Tuesday, October 7, 2008 - 8:47am
tags:
Shire colitis drug 'demonstrates steady medicine release'
Hays Pharma
Tuesday, October 7, 2008 - 8:46am
tags:
Salix Pharmaceuticals (SLXP) Presents Data on Mesalamine Granules Once-Daily Maintained Remission at ACG 2008
Street Insider
Tuesday, October 7, 2008 - 8:40am
tags:
Eli Lilly resolves investigation over Zyprexa with 32 states
Marketwatch
Tuesday, October 7, 2008 - 8:39am
tags:
AtheroGenics Files for Chapter 11 Bankruptcy
Yahoo
Tuesday, October 7, 2008 - 8:22am
tags:
Alpharma agrees to share confidential financials with suitor King Pharmaceuticals
Yahoo/AP
Tuesday, October 7, 2008 - 8:21am
tags:
Medicine for a sector
FT.com
Tuesday, October 7, 2008 - 7:53am
tags:
Medtronic CEO Hawkins Says Stent Patent Win Worth $114 Million
Bloomberg
Tuesday, October 7, 2008 - 7:52am
tags:
UBS Helps Lilly Buy ImClone, Says Price Too High
Bloomberg
Tuesday, October 7, 2008 - 7:50am
tags:
Genentech and Biogen say Rituxan slowed leukemia progress in late stage clinical trial
Yahoo/AP
Tuesday, October 7, 2008 - 7:49am
tags:
Four Thoughts on the Imclone/Lilly Deal
Seeking Alpha
Tuesday, October 7, 2008 - 7:46am
tags:
A Biotech Bonanza for ImClone and Dendreon
Seeking Alpha
Tuesday, October 7, 2008 - 7:45am
tags:
Synavive data sends CombinatoRx to all-time lows
Yahoo/AP
Tuesday, October 7, 2008 - 7:44am
tags:
Fitch may downgrade Eli Lilly's 'AA' on ImClone buy
Marketwatch
Tuesday, October 7, 2008 - 7:43am
tags:

Pages

Latest CP Wire Articles

FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics

Latest Pharmagather Articles

Patient Care’s Next Big Shift: 80% of Leaders Say This Is the Game Changer
Drug Channels
Available for Preorder: The 2025 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers
Drug Channels
The Thiazide Target, At Last
In the Pipeline
Drug Channels News Roundup, February 2025: Part D vs. Pharmacies, Accumulator Madness, Wholesaler Vertical Integration, IRA vs. MDs, and a 340B Cartoon
Drug Channels
Neurodegeneration Might Come Down to RNA
In the Pipeline
From Data Gaps to Revenue Gains: Harnessing the Power of Comprehensive Data to Drive GTN
Drug Channels
Paxlovid: You'd Have Expected More
In the Pipeline
The Continuing Crisis, Part V: What the NIH Is Telling Its People
In the Pipeline
What the Antifungals Are Really Doing
In the Pipeline

Latest Jobs

Clinical Account Executive
Sanford, Florida, 32771
SOFIE
Sales Representative
Airway Heights, Washington, 99001
Bartlett Roofing
Sales Representative
Spokane, Washington, 99208
Bartlett Roofing
Sales Representative - FT Spokane Valley, WA
Spokane, Washington, 99204
Bartlett Roofing
Sales Representative - FT Spokane Valley, WA
Otis Orchards, Washington, 99027
Bartlett Roofing
Sales Representative - Paid Training
Greenacres, Washington, 99016
Bartlett Roofing
Sales Representative - FT (Up to $150,000 annually)
Spokane, Washington, 99216
Bartlett Roofing
Sales Representative - FT (Up to $150,000 annually)
Veradale, Washington, 99037
Bartlett Roofing
Sales Representative - Paid Training
Otis Orchards, Washington, 99027
Bartlett Roofing
Sales Representative
SPOKANE VALLEY, Washington, 99027
Bartlett Roofing
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information